Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community

The Open Respiratory Medicine Journal
Heena KhiroyaEdward F Nash

Abstract

Intravenous antibiotic therapy (IVAT) for CF acute pulmonary exacerbations (APE) can be delivered in hospital or in the community. This study aimed to compare physical activity in CF patients receiving hospital and community-delivered IVAT, as well as other health outcomes. This was a non-randomised parallel group prospective observational study. Hospitalised and community-treated CF adults receiving IVAT for APE were asked to wear ActiGraph® activity monitors, complete the habitual activity estimation scale (HAES), food diary, modified shuttle test (MST) and CFQ-R at the start and end of therapy. Nutritional and clinical outcomes were also compared between the cohorts. The primary outcomes was physical activity measured by the ActiGraph® activity monitors at the beginning and end of treatment in both cohorts. Physical activity (measured and self-reported) was no different between the cohorts, with both hospitalised and community-treated subjects being generally sedentary. Body weight increased significantly in the hospitalised cohort, whereas no difference was seen in the community-treated cohort. FEV1 % predicted and FVC % predicted increased in community-treated subjects, whereas only FVC % predicted increased in hospitalise...Continue Reading

References

May 1, 1988·Archives of Disease in Childhood·J GilbertJ M Littlewood
Apr 7, 1999·The Journal of Infectious Diseases·A HolmesR Goldstein
Jan 22, 2004·Chest·James R YankaskasDavid Rodman
Mar 9, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Eitan KeremUNKNOWN Consensus Committee
Oct 26, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·J ThorntonA K Webb
Jan 5, 2006·Journal of Clinical Nursing·Glenda EsmondAnne Marie McCormack
Aug 1, 2009·The European Respiratory Journal·H HebestreitS Kriemler
Jun 29, 2010·American Journal of Respiratory and Critical Care Medicine·J Michael CollacoPeter J Mogayzel
Dec 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Moran LavieOri Efrati

❮ Previous
Next ❯

Citations

Jul 15, 2020·Sleep & Breathing = Schlaf & Atmung·Sarah Dietz-TerjungMatthias Welsner
May 15, 2021·Sleep Medicine·Carolin-Maria LinkerGerhard Weinreich

❮ Previous
Next ❯

Software Mentioned

ActiLife
IVAT
Statistical Package for Social Sciences ( SPSS )
Dietplan6

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.